1-8 of 8
Xuefeng Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CAR T-cell therapy has comparable efficacy with autologous transplantation in older adults with DLBCL in partial response

Othman S. Akhtar, Biwei Cao, Xuefeng Wang, Pallawi Torka, Mohammed Al-Jumayli, Frederick L. Locke, Ciara L. Freeman
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5937–5940.
https://doi.org/10.1182/bloodadvances.2023010127
Published: 2023
Includes: Supplemental data
Journal Articles

Intraosseous delivery of platelet-targeted factor VIII lentiviral vector in humanized NBSGW mice

Julia H. Joo, Xuefeng Wang, Swati Singh, Chun-Yu Chen, Chong Li, Jennifer E. Adair, Hans-Peter Kiem, David J. Rawlings, Carol H. Miao
Journal: Blood Advances
Blood Adv (2022) 6 (19): 5556–5569.
https://doi.org/10.1182/bloodadvances.2022008079
Published: 2022
Includes: Supplemental data
Journal Articles

CPT2 K79 acetylation regulates platelet life span

Xuemei Fan, Yang Wang, Xiaohong Cai, Yingzhi Shen, Tongran Xu, Yanyan Xu, Jinke Cheng, Xuefeng Wang, Lin Zhang, Jing Dai, Shuhai Lin, Junling Liu
Journal: Blood Advances
Blood Adv (2022) 6 (17): 4924–4935.
https://doi.org/10.1182/bloodadvances.2021006687
Published: 2022
Includes: Supplemental data
Journal Articles

A phase 2 trial of the histone deacetylase inhibitor panobinostat for graft-versus-host disease prevention

Clinical Trials & Observations
Lia Perez, Hugo Fernandez, Mohamed Kharfan-Dabaja, Farhad Khimani, Brian Betts, Asmita Mishra, Ernesto Ayala, Frederick L. Locke, Leonel Ochoa-Bayona, Michael Nieder, Joseph Pidala, Alex Achille, John Powers, Eva Sahakian, Ram Thapa, Xuefeng Wang, Claudio Anasetti
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2740–2750.
https://doi.org/10.1182/bloodadvances.2021004225
Published: 2021
Journal Articles

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

Clinical Trials & Observations
Nelli Bejanyan, Joseph A. Pidala, Xuefeng Wang, Ram Thapa, Taiga Nishihori, Hany Elmariah, Aleksandr Lazaryan, Farhad Khimani, Marco L. Davila, Asmita Mishra, Rawan Faramand, Michael D. Jain, Leonel Ochoa, Lia Elena Perez, Hien Liu, Melissa Alsina, Mohamed A. Kharfan-Dabaja, Hugo Fernandez, Michael L. Nieder, Frederick L. Locke, Claudio Anasetti, Ernesto Ayala
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1154–1163.
https://doi.org/10.1182/bloodadvances.2020003779
Published: 2021
Journal Articles

Enhancing therapeutic efficacy of in vivo platelet-targeted gene therapy in hemophilia A mice

Xuefeng Wang, Richard Y. Fu, Chong Li, Chun-Yu Chen, Jenni Firrman, Barbara A. Konkle, Junping Zhang, Lei Li, Weidong Xiao, Mortimer Poncz, Carol H. Miao
Journal: Blood Advances
Blood Adv (2020) 4 (22): 5722–5734.
https://doi.org/10.1182/bloodadvances.2020002479
Published: 2020
Includes: Supplemental data
Journal Articles

Maternal microchimerism protects hemophilia A patients from inhibitor development

Yeling Lu, Zhenping Chen, Jing Dai, Xi Wu, Hao Gu, Zekun Li, Jian Li, Qiulan Ding, Wenman Wu, Runhui Wu, Xuefeng Wang
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1867–1869.
https://doi.org/10.1182/bloodadvances.2020001832
Published: 2020
Journal Articles

Building a network for hemophilia care in China: 15 years of achievement for the Hemophilia Treatment Center Collaborative Network of China

Renchi Yang, Man-Chiu Poon, Koon Hung Luke, Yongqiang Zhao, Jing Sun, Xuefeng Wang, Runhui Wu, Lixia Chen, Xinsheng Zhang, Jingsheng Wu
Journal: Blood Advances
Blood Adv (2019) 3 (Supplement 1): 34–37.
https://doi.org/10.1182/bloodadvances.2019GS121524
Published: 2019